Icosagen
San Francisco, CA, United States icosagen.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Icosagen is an Estonia-based CRDMO that combines contract research, development, and manufacturing for biopharmaceutical and biotechnology customers. It supports antibody and recombinant protein programs from discovery through cell line and process development to GMP manufacturing, and also offers food microbiology testing and catalogue products. The company operates from Õssu, Kambja vald near Tartu, with a U.S. office in San Francisco.
Services
Early Antibody Developability Assessment
Provides in silico prediction with targeted experimental validation to assess antibody candidates early in development.
Immunization
Designs customized immunization strategies using chicken, rabbit, protein, peptide, DNA, or VLP-based approaches for antibody discovery.
B-Cell Cloning
Uses HybriFree B-cell cloning to convert immunized samples into sequence-defined recombinant antibodies.
Phage Display
Screens naïve and hyperimmune libraries with customized selection strategies to identify target-specific binders.
Hybridoma Sequencing
Recovers antibody variable-region sequences from customer-provided hybridomas and produces recombinant antibodies.
Antibody Development & Engineering
Develops and engineers antibody formats including humanization, affinity maturation, reformatting, bispecifics, and difficult targets.
Antibody-Drug Conjugates
Conjugates antibodies and proteins with drugs, small molecules, peptides, dyes, or oligonucleotides using multiple conjugation methods.
Recombinant Protein Production
Produces recombinant proteins and antibodies using proprietary mammalian expression systems and purification workflows.
Protein production
14 more services
- Transient Expression
- Bispecific Antibodies
- Membrane Protein Expression
- ADCC Enhancement
- Cell Line Development
- Cell-Based Assays
- Protein Purification & Analytics
- GMP Manufacturing
- Upstream process development
- Downstream process development
- Food Microbiology Testing
- Antibody Discovery
- Protein Production
- HPV Assay
- Turnaround
- 3.5 weeks
- What to send
- Customer-provided hybridomas
- Immunized samples
- Food or feed samples
- Samples with prefilled submission forms
- Minimums and prices
- From €220
Capabilities
- Assays and studies
- Antibodies
- Process development
- ADCs
- Bispecifics
- Cell-based assays
- Phage display
17 more
- Hybridoma
- CHO
- Developability assessment
- Biochemical characterization
- Biophysical characterization
- Functional characterization
- Binding assay
- Blocking assay
- Neutralization assay
- Proliferation assay
- Anti-proliferation assay
- ADCC assay
- CDC assay
- ADCP assay
- Microbiological quantification
- Microbiological testing
- HPV assay
- Scale and capacity
- Up to 1000 L scale
- 1400 m² GMP facility
- 50 L, 200 L and 1000 L single-use bioreactors
- Up to 50 L non-GMP manufacturing
- Therapeutic areas
- Antibody discovery
- Diagnostics
- Drug development
- Biologics
- Biotechnology
- Antibody therapeutics
- Protein therapeutics
Instruments and platforms
- 50 L single-use bioreactors
- 200 L single-use bioreactors
- 1000 L single-use bioreactors
Modalities and species
- Modalities
- Small molecule
- Antibody
- Bispecific
- ADC
- Peptide
- Oligonucleotide
- Recombinant protein
- Species and models
- Chicken
- Rabbit
- Human
- Mouse
- Macaque
- Sheep
4 more
- Dog
- Patient-derived PBMCs
- Hybridomas
- CHO cells
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacturing
ISO 9001Self-reported
Details
- Type
- CRDMO
- Founded
- 1999
- Based in
- San Francisco, CA, United States
- Sites
- San Francisco, CA, United States
- Tartu, Estonia
- Serves
- Europe, worldwide, United States